05 Compliance

Where vitamin K2 MK-4 is permitted, and what the file must show

Technical document 05 · Reviewed 2026-11-19 · Vitamin K2 MK-4

On this page
  1. Four checks, not one
  2. European Union
  3. United States
  4. United Kingdom
  5. The limits in the file
  6. Where the claim boundary sits
  7. The document set
  8. A short checklist

Permission for vitamin K2 MK-4 is not the same question as permission for MK-7. The EU novel-food entry for vitamin K2 is written around menaquinone-7; MK-4 is a different substance, sold at doses hundreds of times higher, and the food-supplement, food-additive or medicinal route for the destination has to be confirmed by the buyer's regulatory team. This page sets out the checks, the limits and the documents that belong in the file.

In one line

The vitamin K2 novel-food entry is written around menaquinone-7, so the route for an MK-4 ingredient has to be confirmed for the destination before the label is written.

Four checks, not one

A regulatory file is more than a certificate in a folder. It has to answer four separate questions. Is the substance, at this dose, allowed a route into the market? Does the lot meet the specification that route names? Does the label carry the permitted name, unit and declarations? And is each claim on the pack allowed for this ingredient and this market? Answer only the second and the file proves a lot, not a market.

Any one of them can fail on its own, and for MK-4 the first carries extra weight. At a 45 mg daily dose the product is far above the microgram levels of a typical vitamin K supplement, and a destination may apply a different route to that dose. The form, the source and the dose all belong in the question, not only the name on the certificate.

European Union

Regulation (EU) 2017/2470 establishes the Union list of novel foods. The entry for vitamin K2 (menaquinone) is built on menaquinone-7: its specification sets 97–102% MK-7, with at least 92% all-trans and no more than 6.0% cis isomers, and it describes the homologous series, including the MK-4 formula. What that means for an MK-4 ingredient — whether it can rely on the entry or needs another route — is a question for the buyer's regulatory team, answered against the current consolidated text rather than this summary.

The food-supplement framework is separate. Directive 2002/46/EC lists vitamin K among the vitamins that may be used and sets out the permitted forms in its annexes; the current text and the destination member state's implementing rules decide whether the form supplied can be sold as a vitamin in a supplement. The novel-food catalogue and any national position on the specific substance belong in the file as well. For a 45 mg dose, the label's percentage of the nutrient reference value is also part of the review: the EU reference value for vitamin K is 75 µg, so 45 mg is 60,000% of it.

United States

In the United States, MK-4 sits in the dietary-supplement market under DSHEA. The supplier should say whether the ingredient was on that market before 15 October 1994, or whether a new dietary ingredient notification supports it; the buyer confirms that the basis covers the finished product. Manufacturing falls under the dietary-supplement cGMPs (21 CFR 111); the panel format is set by 21 CFR 101.36.

Vitamin K is declared in micrograms on that panel, so a 45 mg dose appears as 45,000 µg. That is a unit conversion, not a different dose, and it is the kind of figure a reviewer notices. A structure/function statement needs the DSHEA disclaimer and must not be a disease claim.

United Kingdom

Great Britain keeps its own retained novel-food list, held by the Food Standards Agency, and its own food-supplement and labelling rules. The GB list started from the EU list but can diverge as each side amends its text, so a GB check is a separate check. Northern Ireland applies EU rules under the Windsor Framework; a GB-only review does not cover a product sold in Belfast or shipped across the border.

The limits in the file

Catalog release limits that support the compliance file
ParameterCatalog limitWhat the file should show
Heavy metalsPb ≤3 · As ≤2 · Cd ≤1 · Hg ≤0.1 mg/kgMeasured result per element, method, and the finished-product calculation
MicrobiologyAPC ≤1,000 cfu/g; yeast and mould ≤100 cfu/g; E. coli and Salmonella absentMethod and count for the lot
Loss on drying≤0.5%Measured value and its basis
Particle size≥95% through 40 meshSieve method and measured percentage

The table lists catalog release limits; it does not claim that every market sets the same legal ceiling. Each destination sets its own ceilings, some categories are tighter than others, and the finished-product figure depends on the daily dose. The certificate carries the measurement; the file shows where that measurement sits against the limit for the finished product.

Where the claim boundary sits

In the EU, Regulation (EC) No 1924/2006 and the EU Register control nutrition and health claims. A wording may be used only when it appears on the Register, matches its conditions of use and stops short of a disease claim. The Register does carry vitamin K entries, but none is reproduced here and none is relied on; the brand's own reviewer decides whether a wording is available for its product and dose.

“Menaquinone-4”, “MK-4” and the assay figure are specification terms, not claims. In the US the claim review follows the structure/function boundary, with the DSHEA disclaimer and no disease claim. Permission for a wording in one market does not travel to the next.

The document set

Documents a brand should hold for an MK-4 lot
DocumentWhat it should establish
Certificate of analysisLot code, assay and basis, contaminants, microbiology
SpecificationThe release limits the certificate is judged against
Technical data sheetGrade, solubility, particle size, pack and storage
Safety data sheetHandling, transport and storage classification
Allergen and GMO statementsCarrier or oil source, and any declaration the market requires
Source statementThe synthetic route, the starting material and the manufacturing site
Regulatory position statementHow the ingredient maps to the route relied on for the destination

A short checklist

  • Does the file name menaquinone-4, the CAS number and the grade?
  • Does the certificate meet the specification on its stated basis?
  • Is the route confirmed for the destination and the daily dose?
  • Is the label using the permitted name and unit for that market?
  • Is the 45 mg dose expressed correctly on the panel?
  • Is every claim on the pack permitted for this form and market?
  • Is the same lot code on the COA, the pack label and the retained sample?

A file is only as good as the lot behind it, so keep the certificate, the label and the retained sample together. The specification is on the product page, the certificate on the COA page and the identity evidence on the identity page. The vitamin K1 page shows the phylloquinone case, and the quality page covers release.

Send the specification you intend to use — grade, quantity and destination market — and we will reply with the batch COA, the technical data sheet and a quotation.

Request a quotation